BetterLife Pharma Inc., a biotechnology company, engages in the development of psychedelic-derived compounds. It focuses on developing and commercializing BETR-001, a non-hallucinogenic and non-controlled LSD derivative to treat neuro-psychiatric and neurological disorders. Its products also comprise MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and MM-003, a patent pending proprietary interferon alpha-2b inhalation formulation. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does BetterLife Pharma Inc (BETR) operate in?
BetterLife Pharma Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is BetterLife Pharma Inc (BETR) current stock price?
As of the latest data, BetterLife Pharma Inc stock price is CA$0.30, with a previous close of CA$0.32. BetterLife Pharma Inc lost -CA$0.02 in the last trading session, representing a -4.76% loss.
What is BetterLife Pharma Inc (BETR) current market capitalization?
BetterLife Pharma Inc market cap is approximately 48.67 million.
What is BetterLife Pharma Inc (BETR) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.01.
Does BetterLife Pharma Inc (BETR) pay dividends?
No. BetterLife Pharma Inc does not pay a dividend.
What is BetterLife Pharma Inc (BETR) beta (volatility) score?
BetterLife Pharma Inc has a beta of 0.223, indicating lower volatility than the overall market.
